Annual D&A
$568.00 K
+$36.00 K+6.77%
March 31, 2024
Summary
- As of February 8, 2025, VTGN annual depreciation & amortization is $568.00 thousand, with the most recent change of +$36.00 thousand (+6.77%) on March 31, 2024.
- During the last 3 years, VTGN annual D&A has risen by +$90.40 thousand (+18.93%).
- VTGN annual D&A is now -20.12% below its all-time high of $711.10 thousand, reached on March 31, 2022.
Performance
VTGN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$157.00 K
+$6000.00+3.97%
September 30, 2024
Summary
- As of February 8, 2025, VTGN quarterly depreciation & amortization is $157.00 thousand, with the most recent change of +$6000.00 (+3.97%) on September 30, 2024.
- Over the past year, VTGN quarterly D&A has stayed the same.
- VTGN quarterly D&A is now -50.32% below its all-time high of $316.00 thousand, reached on December 31, 2021.
Performance
VTGN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$598.00 K
+$18.00 K+3.10%
September 30, 2024
Summary
- As of February 8, 2025, VTGN TTM depreciation & amortization is $598.00 thousand, with the most recent change of +$18.00 thousand (+3.10%) on September 30, 2024.
- Over the past year, VTGN TTM D&A has stayed the same.
- VTGN TTM D&A is now -15.96% below its all-time high of $711.60 thousand, reached on June 30, 2022.
Performance
VTGN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VTGN Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +6.8% | 0.0% | 0.0% |
| 3 y3 years | +18.9% | 0.0% | 0.0% |
| 5 y5 years | +522.8% | 0.0% | 0.0% |
VTGN Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -20.1% | +18.9% | -50.3% | +21.4% | -16.0% | +13.4% |
| 5 y | 5-year | -20.1% | +522.8% | -50.3% | +518.1% | -16.0% | +484.6% |
| alltime | all time | -20.1% | -100.0% | -50.3% | >+9999.0% | -16.0% | >+9999.0% |
VistaGen Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $157.00 K(+4.0%) | $598.00 K(+3.1%) |
| Jun 2024 | - | $151.00 K(+3.1%) | $580.00 K(+2.1%) |
| Mar 2024 | $568.00 K(+6.8%) | $146.50 K(+2.1%) | $568.00 K(+1.5%) |
| Dec 2023 | - | $143.50 K(+3.2%) | $559.40 K(+2.1%) |
| Sep 2023 | - | $139.00 K(0.0%) | $548.10 K(+1.2%) |
| Jun 2023 | - | $139.00 K(+0.8%) | $541.70 K(+1.8%) |
| Mar 2023 | $532.00 K(-25.2%) | $137.90 K(+4.3%) | $532.00 K(+0.9%) |
| Dec 2022 | - | $132.20 K(-0.3%) | $527.50 K(-25.8%) |
| Sep 2022 | - | $132.60 K(+2.6%) | $711.30 K(-0.0%) |
| Jun 2022 | - | $129.30 K(-3.1%) | $711.60 K(+0.1%) |
| Mar 2022 | $711.10 K(+48.9%) | $133.40 K(-57.8%) | $711.10 K(+0.1%) |
| Dec 2021 | - | $316.00 K(+137.8%) | $710.50 K(+38.9%) |
| Sep 2021 | - | $132.90 K(+3.2%) | $511.70 K(-11.9%) |
| Jun 2021 | - | $128.80 K(-3.0%) | $581.00 K(+21.6%) |
| Mar 2021 | $477.60 K(+363.2%) | $132.80 K(+13.3%) | $477.60 K(+29.0%) |
| Dec 2020 | - | $117.20 K(-42.0%) | $370.30 K(+32.9%) |
| Sep 2020 | - | $202.20 K(+696.1%) | $278.60 K(+172.3%) |
| Jun 2020 | - | $25.40 K(-0.4%) | $102.30 K(-0.8%) |
| Mar 2020 | $103.10 K(+13.0%) | $25.50 K(0.0%) | $103.10 K(-0.9%) |
| Dec 2019 | - | $25.50 K(-1.5%) | $104.00 K(-1.3%) |
| Sep 2019 | - | $25.90 K(-1.1%) | $105.40 K(+2.9%) |
| Jun 2019 | - | $26.20 K(-0.8%) | $102.40 K(+12.3%) |
| Mar 2019 | $91.20 K(+13.0%) | $26.40 K(-1.9%) | $91.20 K(+13.7%) |
| Dec 2018 | - | $26.90 K(+17.5%) | $80.20 K(+10.8%) |
| Sep 2018 | - | $22.90 K(+52.7%) | $72.40 K(+0.4%) |
| Jun 2018 | - | $15.00 K(-2.6%) | $72.10 K(-10.7%) |
| Mar 2018 | $80.70 K(+47.0%) | $15.40 K(-19.4%) | $80.70 K(-2.3%) |
| Dec 2017 | - | $19.10 K(-15.5%) | $82.60 K(+10.0%) |
| Sep 2017 | - | $22.60 K(-4.2%) | $75.10 K(+15.2%) |
| Jun 2017 | - | $23.60 K(+36.4%) | $65.20 K(+18.8%) |
| Mar 2017 | $54.90 K | $17.30 K(+49.1%) | $54.90 K(+9.1%) |
| Dec 2016 | - | $11.60 K(-8.7%) | $50.30 K(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | - | $12.70 K(-4.5%) | $50.60 K(-3.3%) |
| Jun 2016 | - | $13.30 K(+4.7%) | $52.30 K(-2.2%) |
| Mar 2016 | $53.50 K(-9.5%) | $12.70 K(+6.7%) | $53.50 K(-11.9%) |
| Dec 2015 | - | $11.90 K(-17.4%) | $60.70 K(-1.8%) |
| Sep 2015 | - | $14.40 K(-0.7%) | $61.80 K(+2.1%) |
| Jun 2015 | - | $14.50 K(-27.1%) | $60.50 K(+2.4%) |
| Mar 2015 | $59.10 K(+8.2%) | $19.90 K(+53.1%) | $59.10 K(+10.3%) |
| Dec 2014 | - | $13.00 K(-0.8%) | $53.60 K(-2.5%) |
| Sep 2014 | - | $13.10 K(0.0%) | $55.00 K(-0.9%) |
| Jun 2014 | - | $13.10 K(-9.0%) | $55.50 K(+1.6%) |
| Mar 2014 | $54.60 K(+61.5%) | $14.40 K(0.0%) | $54.60 K(+3.0%) |
| Dec 2013 | - | $14.40 K(+5.9%) | $53.00 K(+10.9%) |
| Sep 2013 | - | $13.60 K(+11.5%) | $47.80 K(+19.2%) |
| Jun 2013 | - | $12.20 K(-4.7%) | $40.10 K(+18.6%) |
| Mar 2013 | $33.80 K(-25.9%) | $12.80 K(+39.1%) | $33.80 K(+2.1%) |
| Dec 2012 | - | $9200.00(+55.9%) | $33.10 K(-8.3%) |
| Sep 2012 | - | $5900.00(0.0%) | $36.10 K(-11.3%) |
| Jun 2012 | - | $5900.00(-51.2%) | $40.70 K(-10.7%) |
| Mar 2012 | $45.60 K(>+9900.0%) | $12.10 K(-0.8%) | $45.60 K(+35.7%) |
| Dec 2011 | - | $12.20 K(+16.2%) | $33.60 K(+56.3%) |
| Sep 2011 | - | $10.50 K(-2.8%) | $21.50 K(+93.7%) |
| Jun 2011 | - | $10.80 K(>+9900.0%) | $11.10 K(+2675.0%) |
| Mar 2011 | - | $100.00(0.0%) | $400.00(0.0%) |
| Dec 2010 | $400.00(0.0%) | $100.00(0.0%) | $400.00(0.0%) |
| Sep 2010 | - | $100.00(0.0%) | $400.00(0.0%) |
| Jun 2010 | - | $100.00(0.0%) | $400.00(0.0%) |
| Mar 2010 | - | $100.00(0.0%) | $400.00(0.0%) |
| Dec 2009 | $400.00(>+9900.0%) | $100.00(0.0%) | $400.00(+33.3%) |
| Sep 2009 | - | $100.00(0.0%) | $300.00(+50.0%) |
| Jun 2009 | - | $100.00(0.0%) | $200.00(+100.0%) |
| Mar 2009 | - | $100.00 | $100.00 |
| Dec 2008 | $0.00 | - | - |
FAQ
- What is VistaGen Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for VistaGen Therapeutics?
- What is VistaGen Therapeutics annual D&A year-on-year change?
- What is VistaGen Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for VistaGen Therapeutics?
- What is VistaGen Therapeutics quarterly D&A year-on-year change?
- What is VistaGen Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for VistaGen Therapeutics?
- What is VistaGen Therapeutics TTM D&A year-on-year change?
What is VistaGen Therapeutics annual depreciation & amortization?
The current annual D&A of VTGN is $568.00 K
What is the all time high annual D&A for VistaGen Therapeutics?
VistaGen Therapeutics all-time high annual depreciation & amortization is $711.10 K
What is VistaGen Therapeutics annual D&A year-on-year change?
Over the past year, VTGN annual depreciation & amortization has changed by +$36.00 K (+6.77%)
What is VistaGen Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of VTGN is $157.00 K
What is the all time high quarterly D&A for VistaGen Therapeutics?
VistaGen Therapeutics all-time high quarterly depreciation & amortization is $316.00 K
What is VistaGen Therapeutics quarterly D&A year-on-year change?
Over the past year, VTGN quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is VistaGen Therapeutics TTM depreciation & amortization?
The current TTM D&A of VTGN is $598.00 K
What is the all time high TTM D&A for VistaGen Therapeutics?
VistaGen Therapeutics all-time high TTM depreciation & amortization is $711.60 K
What is VistaGen Therapeutics TTM D&A year-on-year change?
Over the past year, VTGN TTM depreciation & amortization has changed by $0.00 (0.00%)